Similarly while the previous trial reported migraine associated variants, in the MTHFR and MTRR genes to have a significant effect on migraine treatment response, the current trial did not observe any significant effect of the MTHFR C677T gene variant on migraine treatment response. The gene discussed is MTRR; the disease is migraine disorder.